Bisnis.com, JAKARTA - Indonesia’s largest pharmaceutical firm PT Kalbe Farma Tbk. (KLBF) is growing more optimistic as the rupiah stabilizes and its core business remains resilient.
The easing of global trade tensions has also lifted the company’s stock valuation, which had been weighed down by its heavy reliance on imported raw materials.